Clinical trials
Withdrawn Phase 3 Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 1 |
| Hamilton Health Sciences Corporation | 1 |
| Hospital do Coracao | 1 |
| Lantheus Medical Imaging | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| Newmarket Electrophysiology Research Group Inc | 1 |
| Piedmont Healthcare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 7 |
| Cardiovascular Diseases | 2 |
| Heart Diseases | 2 |
| Myocardial Ischemia | 2 |
| Arrhythmias, Cardiac | 1 |
| Arterial Occlusive Diseases | 1 |
| Arteriosclerosis | 1 |
| Atrial Fibrillation | 1 |
| COVID-19 | 1 |
| Coronary Disease | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.